Company / Operating Cash Flow per Share
GERON CORP Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.34
FY2024
5-year range
-$0.43 / -$0.11
FY2020-FY2024
Trend
+21.3%
vs FY2023
Sector context
#90 of 212
Health Care
What the data says
At $-0.34, GERON CORP's operating cash flow per share ranks #90 of 212 in the Health Care sector. Operating Cash Flow per Share returned to growth in FY2024 after 3 years of decline, reaching $-0.34.
Based on SEC 10-K filings.
-0.34 in FY2024.
Improved from $-0.39 to $-0.34 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 212 in Health CareTop 42% of 212This company -$0.34 Sector average $5.28
▼
-106.4% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 21.3% year-over-year.
- Ranks #90 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.34 | +21.3% |
| FY2023 | -$0.43 | -9.2% |
| FY2022 | -$0.39 | -178.8% |
| FY2021 | -$0.14 | -34.2% |
| FY2020 | -$0.11 | +4.7% |
| FY2019 | -$0.11 | +4.0% |
| FY2018 | -$0.11 | +24.4% |
| FY2017 | -$0.15 | -358.2% |
| FY2016 | $0.06 | +125.3% |
| FY2015 | -$0.23 | +44.8% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026